Our analysis shows that CXCL13 levels were significantly elevated in the sera of women with both early and late stage ovarian cancer, and the AUC values ranged from 0.71 (early stage) to 0.92 (late stage) when comparing cancer to healthy or benign samples. The gene discussed is CXCL13; the disease is cancer.